Insight Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Insight Advisors's AMGN Position: Q2 2026 in Review
Insight Advisors reduced its Amgen (AMGN) stake by 1.2% in Q2 2026, selling an estimated $7.87K and leaving 1,857 shares worth $672K. The position accounts for 0.12% of the portfolio, ranked #111.
Insight Advisors first reported a position in AMGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $703K in Q4 2022. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Insight Advisors held 1,857 shares of Amgen worth $672K as of Q2 2026.
- Insight Advisors sold 23 Amgen shares in Q2 2026, an estimated $7.87K.
- Amgen made up 0.12% of Insight Advisors's portfolio in Q2 2026, its #111 holding.
- Insight Advisors first reported a position in Amgen in Q4 2020 and has held it in 23 quarters since.
- Insight Advisors's Amgen position peaked at $703K in Q4 2022.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Insight Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.